These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2068893

  • 1. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus.
    Hother-Nielsen O, Beck-Nielsen H.
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):637-45. PubMed ID: 2068893
    [Abstract] [Full Text] [Related]

  • 2. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [Abstract] [Full Text] [Related]

  • 3. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia.
    Giacca A, Groenewoud Y, Tsui E, McClean P, Zinman B.
    Diabetes; 1998 Nov; 47(11):1763-70. PubMed ID: 9792546
    [Abstract] [Full Text] [Related]

  • 4. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.
    Pigon J, Giacca A, Ostenson CG, Lam L, Vranic M, Efendic S.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3702-8. PubMed ID: 8855826
    [Abstract] [Full Text] [Related]

  • 8. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [Abstract] [Full Text] [Related]

  • 9. Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
    Staehr P, Hojlund K, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabet Med; 2003 Oct; 20(10):816-22. PubMed ID: 14510862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP.
    Diabete Metab; 1988 Oct; 14(4):443-51. PubMed ID: 3066652
    [Abstract] [Full Text] [Related]

  • 13. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [Abstract] [Full Text] [Related]

  • 14. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
    Vestergaard H, Parving HH, Hansen L, Pedersen O.
    Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
    [Abstract] [Full Text] [Related]

  • 15. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
    Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O.
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
    [Abstract] [Full Text] [Related]

  • 16. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J.
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [Abstract] [Full Text] [Related]

  • 17. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
    Bak JF, Møller N, Schmitz O, Saaek A, Pedersen O.
    Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
    [Abstract] [Full Text] [Related]

  • 18. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC.
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [Abstract] [Full Text] [Related]

  • 19. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.
    DeFronzo RA, Simonson D, Ferrannini E.
    Diabetologia; 1982 Oct; 23(4):313-9. PubMed ID: 6754515
    [Abstract] [Full Text] [Related]

  • 20. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.